Bilophila

Bilophila wadsworthia is a Gram-negative, obligate anaerobic, sulfite-reducing bacterium that has emerged as a key pathobiont linking high-fat diets, taurine metabolism, hydrogen sulfide production, and inflammatory disease. Its unique metabolic niche — using taurine-conjugated bile acids as an electron acceptor — positions it at the intersection of dietary fat intake, bile acid metabolism, and gut inflammation.

Metabolic Specialization

Taurine to H2S Pathway

  • B. wadsworthia metabolizes taurine (from taurine-conjugated bile acids) via taurine dehydrogenase, producing hydrogen sulfide (H2S) as an end product.
  • H2S is genotoxic, inhibits butyrate oxidation in colonocytes, and disrupts the mucus barrier.
  • Taurine-conjugated bile acids increase with high-saturated-fat diets, providing the metabolic substrate that fuels B. wadsworthia expansion.

Hydrogen Utilization

  • Uses H2 as an energy source via hydrogenase enzymes, positioning it within the gut hydrogen economy.
  • H2 consumption by B. wadsworthia can shift the thermodynamics of fermentation by other gut bacteria, influencing overall community metabolism.

Iron and Molybdenum Dependencies

  • The dissimilatory sulfite reductase (DsrAB) that generates H2S contains iron-sulfur clusters, making B. wadsworthia dependent on iron availability.
  • Taurine dehydrogenase requires a molybdenum cofactor, linking its pathogenic metabolism to trace metal availability.

Disease Associations

Colorectal Cancer

  • Significantly more abundant in uninvolved colonic mucosa of CRC cases versus controls among African American/Black individuals [1].
  • H2S production dampens butyrate metabolism in colonocytes, creating a pro-tumorigenic environment.
  • Mediterranean diet intervention aims to reduce B. wadsworthia abundance by shifting bile acid conjugation patterns away from taurine.

Multiple Sclerosis

  • Enriched in MS progressors (patients with worsening disability) and significantly stratifies disease progression risk in Kaplan-Meier analysis [2].
  • As a sulfate-reducing bacterium producing H2S, it may drive oxidative stress and inflammation in the gut brain axis.
  • May thrive in metal-rich environments, connecting MS progression to environmental metal exposure.

Cardiovascular Disease

  • Correlated with altered lipid metabolites (traumatic acid) in viral myocarditis models [3].
  • Hypertension MR studies show decreased Bilophila in hypertensive individuals [4].

IBD

  • Enriched in inflammatory bowel disease, where its H2S production exacerbates mucosal inflammation.
  • Taurine-rich diets (high in animal protein) promote B. wadsworthia expansion and colitis in susceptible hosts.

Other Conditions

  • Arsenic exposure increases Bilophila abundance and perturbs bile acid homeostasis [5].
  • Altered in autism spectrum disorder gut mycobiome-bacteriome interaction studies [6].
  • Decreased in Huntington's disease [7].

Dietary Modulation

The abundance of B. wadsworthia is highly responsive to diet:

  • Increased by: high-saturated-fat diets, high-taurine diets (animal protein), Western-style diets.
  • Decreased by: Mediterranean diet, plant-based diets, high-fiber diets that shift bile acid profiles toward glycine conjugation.

Connections

References (7)

  1. . mcleod 2023 bridge crc mediterranean diet trial
  2. . montgomery 2024 microbiota signatures ms progression
  3. . xue 2024 colonic microflora metabolic viral myocarditis cvb3
  4. . li 2023 gut microbiome hypertension bidirectional mr
  5. . zhu 2024 toxic essential metals gut microbiota
  6. . strati 2017 altered gut microbiota mycobiota asd
  7. . khatoon 2023 gut microbiota neurodegenerative